These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16453257)

  • 1. Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen.
    Chen Z; Moayeri M; Zhou YH; Leppla S; Emerson S; Sebrell A; Yu F; Svitel J; Schuck P; St Claire M; Purcell R
    J Infect Dis; 2006 Mar; 193(5):625-33. PubMed ID: 16453257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel chimpanzee/human monoclonal antibodies that neutralize anthrax lethal factor, and evidence for possible synergy with anti-protective antigen antibody.
    Chen Z; Moayeri M; Crown D; Emerson S; Gorshkova I; Schuck P; Leppla SH; Purcell RH
    Infect Immun; 2009 Sep; 77(9):3902-8. PubMed ID: 19528217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
    Steiniger SC; Altobell LJ; Zhou B; Janda KD
    Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
    Kelly-Cirino CD; Mantis NJ
    Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.
    Pelat T; Hust M; Laffly E; Condemine F; Bottex C; Vidal D; Lefranc MP; Dübel S; Thullier P
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2758-64. PubMed ID: 17517846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies.
    Nguyen ML; Crowe SR; Kurella S; Teryzan S; Cao B; Ballard JD; James JA; Farris AD
    Infect Immun; 2009 Jan; 77(1):162-9. PubMed ID: 18981257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.
    Staats HF; Alam SM; Scearce RM; Kirwan SM; Zhang JX; Gwinn WM; Haynes BF
    Infect Immun; 2007 Nov; 75(11):5443-52. PubMed ID: 17709410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of monoclonal antibodies to anthrax toxin manifest new properties in neutralization assays.
    Pohl MA; Rivera J; Nakouzi A; Chow SK; Casadevall A
    Infect Immun; 2013 Jun; 81(6):1880-8. PubMed ID: 23509144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
    Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
    Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of lethal toxin neutralization by a human monoclonal antibody specific for the PA(20) region of Bacillus anthracis protective antigen.
    Reason D; Liberato J; Sun J; Camacho J; Zhou J
    Toxins (Basel); 2011 Aug; 3(8):979-90. PubMed ID: 22069752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.
    Maynard JA; Maassen CB; Leppla SH; Brasky K; Patterson JL; Iverson BL; Georgiou G
    Nat Biotechnol; 2002 Jun; 20(6):597-601. PubMed ID: 12042864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.
    Albrecht MT; Li H; Williamson ED; LeButt CS; Flick-Smith HC; Quinn CP; Westra H; Galloway D; Mateczun A; Goldman S; Groen H; Baillie LW
    Infect Immun; 2007 Nov; 75(11):5425-33. PubMed ID: 17646360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human monoclonal anti-protective antigen antibody for the low-dose post-exposure prophylaxis and treatment of Anthrax.
    Tang Q; Xiong S; Liang X; Kuai X; Wang Y; Wang C; Feng Z; Zhu J
    BMC Infect Dis; 2018 Dec; 18(1):640. PubMed ID: 30526504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
    J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel mechanism for antibody-based anthrax toxin neutralization: inhibition of prepore-to-pore conversion.
    Mechaly A; Levy H; Epstein E; Rosenfeld R; Marcus H; Ben-Arie E; Shafferman A; Ordentlich A; Mazor O
    J Biol Chem; 2012 Sep; 287(39):32665-73. PubMed ID: 22869370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694.
    Laffly E; Danjou L; Condemine F; Vidal D; Drouet E; Lefranc MP; Bottex C; Thullier P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3414-20. PubMed ID: 16048955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive vaccination with a human monoclonal antibody: generation of antibodies and studies for efficacy in Bacillus anthracis infections.
    vor dem Esche U; Huber M; Zgaga-Griesz A; Grunow R; Beyer W; Hahn U; Bessler WG
    Immunobiology; 2011 Jul; 216(7):847-53. PubMed ID: 21397977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding.
    Chen Z; Moayeri M; Zhao H; Crown D; Leppla SH; Purcell RH
    Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13487-92. PubMed ID: 19651602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An anthrax lethal factor-neutralizing monoclonal antibody protects rats before and after challenge with anthrax toxin.
    Lim NK; Kim JH; Oh MS; Lee S; Kim SY; Kim KS; Kang HJ; Hong HJ; Inn KS
    Infect Immun; 2005 Oct; 73(10):6547-51. PubMed ID: 16177329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthrax lethal toxin (LeTx) neutralization by PA domain specific antisera.
    Verma M; Suryanarayana N; Tuteja U; Thavachelvam K; Rao MK; Bhargava R; Shukla S
    Toxicon; 2017 Dec; 139():58-65. PubMed ID: 28919458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.